The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.
Treatment-Related Mortality in Patients With Advanced-Stage Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group Tumor largest basal diameter and thickness of 7,369 patients were analyzed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results